2552.HK Hua Medicine Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
06:41
Aug 21
Li Chen Executive Director and CEO, Hua Medicine Bloomberg Markets
Hua diabetes drug expands hospitals globally.
Hua Medicine's global first-in-class diabetes drug drove 74% revenue growth, with hospital and sales force expansion underway; Hong Kong's one-plus regulatory path and new indications support global scale.
2552.HK 1ST
HIGH

About 2552.HK Analyst Coverage

Buzzberg tracks 2552.HK (Hua Medicine) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: Li Chen.